MALAT1 and hematopoietic and lymphoid cell neoplasm: MALAT1 in another hematological cancer, multiple myeloma (MM) has been shown to also target latent transforming growth factor beta-binding protein 3 (LTB3) and suggest that MALAT1 may have widespread effects across different transcription complexes [28–30].